RetractedArticleOncoTargets and therapy2020

Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma.

Ping Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.